Abstract
Mitochondria have a well-recognized role in the production of ATP and the intermediates needed for macromolecule biosynthesis, such as nucleotides. Mitochondria also participate in the activation of signaling pathways. Overall, accumulating evidence now suggests that mitochondrial bioenergetics, biosynthesis and signaling are required for tumorigenesis. Thus, emerging studies have begun to demonstrate that mitochondrial metabolism is potentially a fruitful arena for cancer therapy. In this Perspective, we highlight recent developments in targeting mitochondrial metabolism for the treatment of cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 9-15 |
Number of pages | 7 |
Journal | Nature Chemical Biology |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2015 |
Funding
This work is supported US National Institutes of Health grants R01CA123067 to N.S.C. and 5T32HL076139-10 to S.E.W. We apologize to all investigators whose work could not be cited due to reference limitations.
ASJC Scopus subject areas
- Molecular Biology
- Cell Biology